She dives into the challenges around AI, the shift to access-based models, and the reality of lower-than-expected reimbursement rates. The takeaway? It’s no longer enough to promise impact - companies must prove outcomes. If health tech solutions can’t clearly demonstrate value within the access model, they risk being left behind.
Kat also brings a powerful perspective on women’s health, calling for menopause to be treated as more than a quick fix or “patch.” She advocates for deeper research and more meaningful innovation in an area that has long been overlooked.
This conversation is a candid look at where health tech is headed—and what it will take to survive and succeed.